​
​

InMed Pharmaceuticals (INM) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

InMed Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$6.56B

Latest Revenue (Q)

$2.04B

InMed Pharmaceuticals Revenue by Period

InMed Pharmaceuticals Revenue by Year

DateRevenueChange
2023-06-30$6.56B601968.87%
2022-06-30$1.09M100.00%
2021-06-30-100.00%
2020-06-30-100.00%
2019-06-30-100.00%
2018-06-30-100.00%
2017-06-30-100.00%
2016-06-30-100.00%
2015-06-30-100.00%
2014-06-30-100.00%
2013-06-30-100.00%
2012-06-30--100.00%
2011-06-30$39.66K-50.09%
2010-06-30$79.46K-52.82%
2009-06-30$168.42K-72.98%
2008-06-30$623.37K-64.11%
2007-06-30$1.74M-37.01%
2006-06-30$2.76M-34.85%
2005-06-30$4.23M102.27%
2004-07-31$2.09M1027.38%
2003-07-31$185.61K1248.04%
2002-07-31$13.77K463.69%
2001-07-31$2.44K-

InMed Pharmaceuticals generated $6.56B in revenue during NA 2023, up 601968.87% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

InMed Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30$2.04B158571.60%
2024-06-30$1.28M9.42%
2024-03-31$1.17M-5.45%
2023-12-31$1.24M-26.60%
2023-09-30$1.69M-26.89%
2023-06-30$2.31M123.52%
2023-03-31$1.03M120.09%
2022-12-31$469.78K46.45%
2022-09-30$320.79K-37.68%
2022-06-30$514.76K66.27%
2022-03-31$309.58K16.78%
2021-12-31$265.09K100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30--100.00%
2011-06-30$138.33-99.33%
2011-03-31$20.78K128.68%
2010-12-31$9.09K2.82%
2010-09-30$8.84K-82.89%
2010-06-30$51.66K721.74%
2010-03-31$6.29K113.95%
2009-12-31$2.94K-83.34%
2009-09-30$17.64K-41.52%
2009-06-30$30.16K238.31%
2009-03-31$8.92K-72.88%
2008-12-31$32.88K-71.77%
2008-09-30$116.48K-118.92%
2008-06-30$-615.65K-

InMed Pharmaceuticals generated $2.04B in revenue during Q1 2025, up 158571.60% compared to the previous quarter, and up 88091.98% compared to the same period a year ago.

InMed Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
INMInMed Pharmaceuticals$6.56B$2.04B
SGTXSigilon Therapeutics$12.94M$5.90M
TNXPTonix Pharmaceuticals$7.77M$2.82M
BDRXBiodexa Pharmaceuticals$381.00K$41.50K
PALIPalisade Bio$250.00K-
SONNSonnet BioTherapeutics$147.81K-
VRAXVirax Biolabs Group$8.56K$76.50K
REVBRevelation Biosciences--
ICUSeaStar Medical--
ATNF180 Life Sciences--
DRUGBright Minds Biosciences--
GOVXGeoVax Labs-$300.68K
PHIOPhio Pharmaceuticals--
ZVSAZyVersa Therapeutics--
IMMXImmix Biopharma--
ALLRAllarity Therapeutics--
VIRIVirios Therapeutics--
QNRXQuoin Pharmaceuticals--

INM Revenue FAQ

What is InMed Pharmaceuticals’s yearly revenue?

InMed Pharmaceuticals's yearly revenue for 2023 was $6.56B, representing an increase of 601968.87% compared to 2022. The company's yearly revenue for 2022 was $1.09M, representing an increase of 100.00% compared to 2021. INM's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is InMed Pharmaceuticals’s quarterly revenue?

InMed Pharmaceuticals's quarterly revenue for Q1 2025 was $2.04B, a 158571.60% increase from the previous quarter (Q4 2024), and a 120397.21% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $1.28M, a 9.42% increase from the previous quarter (Q3 2024), and a -44.48% decrease year-over-year (Q4 2023). INM's quarterly revenue for Q3 2024 was $1.17M, a -5.45% decrease from the previous quarter (Q2 2024), and a 13.41% increase year-over-year (Q3 2023).

What is InMed Pharmaceuticals’s revenue growth rate?

InMed Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.